Somatostatin [clinicaltrials_resource:90205c88a671a50621ed64e77c86b7fc]
Comparison of Lanreotide AutogelĀ® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome [clinicaltrials:NCT00092287]Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone [clinicaltrials:NCT00121914]Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding [clinicaltrials:NCT00152399]Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers [clinicaltrials:NCT00222092]Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors [clinicaltrials:NCT00227773]Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study [clinicaltrials:NCT00309283]Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma [clinicaltrials:NCT00386984]Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters [clinicaltrials:NCT00431665]clinicaltrials:NCT00447499clinicaltrials:NCT00495846Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery [clinicaltrials:NCT00500227]Acute Application of Pegvisomant and Octreotide in Acromegaly [clinicaltrials:NCT00595140]Cardiovascular Outcome After Surgery or Somatostatin Analogues [clinicaltrials:NCT00615004]Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer [clinicaltrials:NCT00630695]Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients [clinicaltrials:NCT00652379]clinicaltrials:NCT00703079Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly [clinicaltrials:NCT00765323]clinicaltrials:NCT00774930clinicaltrials:NCT00786825Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness [clinicaltrials:NCT00793741]Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding [clinicaltrials:NCT00966355]DOTA-TOC in Metastasized Neuroendocrine Tumors [clinicaltrials:NCT00978211]clinicaltrials:NCT00990535Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly [clinicaltrials:NCT00994214]Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome [clinicaltrials:NCT01018953]New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma [clinicaltrials:NCT01053390]Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring Method [clinicaltrials:NCT01058577]clinicaltrials:NCT01060826Peripheral Metabolic Effects of Somatostatin [clinicaltrials:NCT01062529]Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy [clinicaltrials:NCT01070758]Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction [clinicaltrials:NCT01082627]EVL (Endoscopic Variceal Ligation) Plus Vasoconstrictor vs.Ligation Plus PPI( Proton Pump Inhibitor) in the Control of Acute Esophageal Variceal Bleeding [clinicaltrials:NCT01112852]clinicaltrials:NCT01128192clinicaltrials:NCT01203306177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms [clinicaltrials:NCT01237457]A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding [clinicaltrials:NCT01267669]Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation. [clinicaltrials:NCT01290172]Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs [clinicaltrials:NCT01371045]Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency [clinicaltrials:NCT01377246]Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices [clinicaltrials:NCT01426087]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Somatostatin [clinicaltrials_resource:90205c88a671a50621ed64e77c86b7fc]
Bio2RDF identifier
90205c88a671a50621ed64e77c86b7fc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:90205c88a671a50621ed64e77c86b7fc
identifier
clinicaltrials_resource:90205c88a671a50621ed64e77c86b7fc
title
Somatostatin
@en
type
label
Somatostatin [clinicaltrials_resource:90205c88a671a50621ed64e77c86b7fc]
@en